A case of long-term survival in P1CY1 gastric cancer responding to combined chemotherapy with low-dose CDDP intraperitoneal administration

Yusuke Watanabe, Motoki Ninomiya, Yasuhiro Cyoda, Masahiko Nishizaki, Shinichiro Watanabe, Teppei Ohnishi, Shinsuke Sasada, Shinichi Urano, Masao Harano, Hiroyoshi Matsukawa, Yasutomo Ojima, Shigehiro Shiozaki, Satoshi Ohno

Research output: Contribution to journalArticle

Abstract

We reported a case of P1CY1 gastric cancer with intraperitoneal chemotherapy after surgery for more than four years. The patient was a 69-year-old male who had suffered from Type I + Type 0 IIc, T3 gastric cancer. He underwent total gastrectomy with D2 dissection. Operative findings revealed P1CY1, and it resulted in non-curative resection. After surgery, combined chemotherapy with low-dose CDDP intraperitoneal administration and UFT, and then combined chemotherapy with paclitaxel and 5-FU were performed. He also underwent palliative surgery for intestinal obstruction resulting from carcinomatous peritonitis. He achieved long-term survival by multidisciplinary therapy of chemotherapy and surgery.

Original languageEnglish
Pages (from-to)2061-2063
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Volume36
Issue number12
Publication statusPublished - Nov 2009
Externally publishedYes

Keywords

  • Chemotherapy
  • Gastric cancer
  • Intraperitoneal administration

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'A case of long-term survival in P1CY1 gastric cancer responding to combined chemotherapy with low-dose CDDP intraperitoneal administration'. Together they form a unique fingerprint.

  • Cite this

    Watanabe, Y., Ninomiya, M., Cyoda, Y., Nishizaki, M., Watanabe, S., Ohnishi, T., Sasada, S., Urano, S., Harano, M., Matsukawa, H., Ojima, Y., Shiozaki, S., & Ohno, S. (2009). A case of long-term survival in P1CY1 gastric cancer responding to combined chemotherapy with low-dose CDDP intraperitoneal administration. Japanese Journal of Cancer and Chemotherapy, 36(12), 2061-2063.